GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Price-to-Operating-Cash-Flow

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Price-to-Operating-Cash-Flow : 15.40 (As of May. 21, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings Price-to-Operating-Cash-Flow?

As of today (2024-05-21), Integrated Diagnostics Holdings's share price is $0.308. Integrated Diagnostics Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.02. Hence, Integrated Diagnostics Holdings's Price-to-Operating-Cash-Flow Ratio for today is 15.40.

The historical rank and industry rank for Integrated Diagnostics Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:

IDGXF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.47   Med: 13.42   Max: 36.33
Current: 16.03

During the past 12 years, Integrated Diagnostics Holdings's highest Price-to-Operating-Cash-Flow Ratio was 36.33. The lowest was 3.47. And the median was 13.42.

IDGXF's Price-to-Operating-Cash-Flow is ranked better than
56.14% of 114 companies
in the Medical Diagnostics & Research industry
Industry Median: 18.61 vs IDGXF: 16.03

Integrated Diagnostics Holdings's Cash Flow from Operations per share for the three months ended in Jun. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.02.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Integrated Diagnostics Holdings was 107.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -32.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -17.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -1.10% per year.

During the past 12 years, Integrated Diagnostics Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 66.70% per year. The lowest was -42.10% per year. And the median was -0.65% per year.


Integrated Diagnostics Holdings Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Integrated Diagnostics Holdings's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Price-to-Operating-Cash-Flow Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.89 11.70 5.33 45.29 11.62

Integrated Diagnostics Holdings Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.00 45.29 - 24.03 -

Competitive Comparison of Integrated Diagnostics Holdings's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Diagnostics Holdings's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's Price-to-Operating-Cash-Flow falls into.



Integrated Diagnostics Holdings Price-to-Operating-Cash-Flow Calculation

Integrated Diagnostics Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.308/0.02
=15.40

Integrated Diagnostics Holdings's Share Price of today is $0.308.
Integrated Diagnostics Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Integrated Diagnostics Holdings Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
12 Castle Street, Saint Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN 09-24-2021